| 1 |
Artusa V, Calabrone L, Mortara L, Peri F, Bruno A. Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory. Int J Mol Sci 2023;24. [PMID: 36902427 DOI: 10.3390/ijms24054997] [Reference Citation Analysis]
|
| 2 |
Zhang G, Xu X, Zhu L, Li S, Chen R, Lv N, Li Z, Wang J, Li Q, Zhou W, Yang P, Liu J. A Novel Molecular Classification Method for Glioblastoma Based on Tumor Cell Differentiation Trajectories. Stem Cells International 2023;2023:1-27. [DOI: 10.1155/2023/2826815] [Reference Citation Analysis]
|
| 3 |
Huang P, Liu M, Zhang J, Zhong X, Zhong C. YTHDF1 Attenuates TBI-Induced Brain-Gut Axis Dysfunction in Mice. Int J Mol Sci 2023;24. [PMID: 36835655 DOI: 10.3390/ijms24044240] [Reference Citation Analysis]
|
| 4 |
Mejía-Rodríguez R, Romero-Trejo D, González RO, Segovia J. Combined treatments with AZD5363, AZD8542, curcumin or resveratrol induce death of human glioblastoma cells by suppressing the PI3K/AKT and SHH signaling pathways. Biochem Biophys Rep 2023;33:101430. [PMID: 36714540 DOI: 10.1016/j.bbrep.2023.101430] [Reference Citation Analysis]
|
| 5 |
Chulpanova DS, Rizvanov AA, Solovyeva VV. The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity. Int J Mol Sci 2022;24. [PMID: 36613838 DOI: 10.3390/ijms24010395] [Reference Citation Analysis]
|
| 6 |
Guerrero-Rodríguez SL, Mata-Cruz C, Pérez-Tapia SM, Velasco-Velázquez MA. Role of CD36 in cancer progression, stemness, and targeting. Front Cell Dev Biol 2022;10:1079076. [PMID: 36568966 DOI: 10.3389/fcell.2022.1079076] [Reference Citation Analysis]
|
| 7 |
Ma T, Li H, Zhang X. Discovering single-cell eQTLs from scRNA-seq data only. Gene 2022;829:146520. [PMID: 35452708 DOI: 10.1016/j.gene.2022.146520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Figarella-branger D, Colin C, Baeza-kallee N, Tchoghandjian A. A2B5 Expression in Central Nervous System and Gliomas. IJMS 2022;23:4670. [DOI: 10.3390/ijms23094670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Rodriguez SMB, Staicu GA, Sevastre AS, Baloi C, Ciubotaru V, Dricu A, Tataranu LG. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer. Int J Mol Sci 2022;23:4602. [PMID: 35562993 DOI: 10.3390/ijms23094602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Herreros-pomares A. Identification, Culture and Targeting of Cancer Stem Cells. Life 2022;12:184. [DOI: 10.3390/life12020184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Peng Y, Shi C, Kistenev YV, Vrazhnov DA, Cherkasova OP. Indirect Imaging. Advances in Brain Imaging Techniques 2022. [DOI: 10.1007/978-981-19-1352-5_10] [Reference Citation Analysis]
|
| 12 |
Ma T, Li H, Zhang X. Discovering single-cell eQTLs from scRNA-seq data only.. [DOI: 10.1101/2021.06.10.447906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Wang Z, Zhang H, Xu S, Liu Z, Cheng Q. The adaptive transition of glioblastoma stem cells and its implications on treatments. Signal Transduct Target Ther 2021;6:124. [PMID: 33753720 DOI: 10.1038/s41392-021-00491-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 14 |
Peixoto J, Janaki-Raman S, Schlicker L, Schmitz W, Walz S, Winkelkotte AM, Herold-Mende C, Soares P, Schulze A, Lima J. Integrated Metabolomics and Transcriptomics Analysis of Monolayer and Neurospheres from Established Glioblastoma Cell Lines. Cancers (Basel) 2021;13:1327. [PMID: 33809510 DOI: 10.3390/cancers13061327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
Su C, Zhang J, Yarden Y, Fu L. The key roles of cancer stem cell-derived extracellular vesicles. Signal Transduct Target Ther 2021;6:109. [PMID: 33678805 DOI: 10.1038/s41392-021-00499-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 16 |
Galdieri L, Jash A, Malkova O, Mao DD, DeSouza P, Chu YE, Salter A, Campian JL, Naegle KM, Brennan CW, Wakimoto H, Oh ST, Kim AH, Chheda MG. Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry. JCI Insight 2021;6:128456. [PMID: 33400685 DOI: 10.1172/jci.insight.128456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Evrysthenis Vartholomatos, George Vartholomatos, George A. Alexiou, Georgios S. Markopoulos. The Past, Present and Future of Flow Cytometry in Central Nervous System Malignancies. Methods Protoc 2021;4:11. [PMID: 33530325 DOI: 10.3390/mps4010011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 18 |
Drazdauskaitė G, Layhadi JA, Shamji MH. Mechanisms of Allergen Immunotherapy in Allergic Rhinitis. Curr Allergy Asthma Rep 2020;21:2. [PMID: 33313967 DOI: 10.1007/s11882-020-00977-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 19 |
Giordano M, Cavallaro U. Different Shades of L1CAM in the Pathophysiology of Cancer Stem Cells. J Clin Med 2020;9:E1502. [PMID: 32429448 DOI: 10.3390/jcm9051502] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 20 |
Erhart F, Hackl M, Hahne H, Buchroithner J, Meng C, Klingenbrunner S, Reitermaier R, Fischhuber K, Skalicky S, Berger W, Spiegl-Kreinecker S, Lötsch D, Ricken G, Kuster B, Wöhrer A, Widhalm G, Hainfellner J, Felzmann T, Dohnal AM, Marosi C, Visus C. Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors. NPJ Vaccines 2020;5:5. [PMID: 31969991 DOI: 10.1038/s41541-019-0149-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 21 |
Liu WH, Lin JC, Chou YC, Li MH, Tsai JT. CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage. Cancer Med 2020;9:350-60. [PMID: 31746135 DOI: 10.1002/cam4.2714] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 22 |
Bezuidenhout N, Shoshan M. A Shifty Target: Tumor-Initiating Cells and Their Metabolism. Int J Mol Sci 2019;20:E5370. [PMID: 31661927 DOI: 10.3390/ijms20215370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Erhart F, Blauensteiner B, Zirkovits G, Printz D, Soukup K, Klingenbrunner S, Fischhuber K, Reitermaier R, Halfmann A, Lötsch D, Spiegl-Kreinecker S, Berger W, Visus C, Dohnal A. Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature. J Cell Mol Med 2019;23:281-92. [PMID: 30467961 DOI: 10.1111/jcmm.13927] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
